Fujifilm works with the following partners to provide additional features for Aspire HD and Aspire HD Plus

iCAD VuCOMP Volpara Solutions

iCAD is an industry-leading provider of Computer-Aided Detection (CAD) technologies, advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. iCAD offers a comprehensive range of high-performance, upgradeable CAD solutions for mammography and advanced image analysis and workflow solutions for Magnetic Resonance Imaging, for breast and prostate cancers and Computed Tomography for colorectal cancer. iCAD's Xoft System, offers radiation treatment for early-stage breast cancer that can be administered in the form of Intraoperative Radiation Therapy or accelerated partial breast irradiation. The Xoft System is also cleared for the treatment of non-melanoma skin cancer and gynecological cancers.

For more information, call (877) iCADnow, or visit www.icadmed.com.

Pioneering some of the world's most advanced computer vision systems, VuCOMP's core team of engineers have worked together since 1986. This team founded VuCOMP with the primary goal of applying their deep understanding of imaging systems to improving early cancer detection.

Every product that VuCOMP develops is created with the singular intent of helping physicians find cancer sooner. Our M-Vu CAD® was the first mammography CAD proven to increase radiologists' effectiveness in both detecting cancer and differentiating cancer from non-cancer in an FDA-approved study.

M-Vu Breast Density, the newest product in the VuCOMP portfolio, is designed to advance the science of breast density measurement. Used in tandem with the M-Vu CAD system for mammography, M-Vu Breast Density equips physicians with another innovative tool to employ in mammography screening.

VuCOMP is headquartered in Plano, Texas, part of the Dallas high technology region, with a global network of sales and product support.

For more information visit www.vucomp.com.

Volpara Solutions builds innovative, quantitative breast imaging solutions tools built on the Volpara algorithm which enables the generation of volumetric measurements of density, patient specific dose, breast compression and other factors that provide actionable intelligence designed to help maintain accuracy and consistent quality in breast screening.

To date, more than 2 million women have had their volumetric breast density analyzed using VolparaDensity. Cleared by the FDA, HealthCanada, the TGA and CE-marked, VolparaDensity is used by radiologists to objectively assess density from both digital mammography and tomosynthesis images and help evaluate who might benefit from additional screening. Highly correlated to breast MR assessments, VolparaDensity is a reliable tool which automatically generates an objective, automatic measurement of volumetric breast density and a FDA cleared BI-RADS breast density category.

VolparaAnalytics assists in quality assurance by monitoring critical elements of the breast imaging process and generating key metrics to help understand the performance of technologists, readers, and mammography and tomosynthesis machines.

VolparaDose improves the accuracy of mammography dose reporting by using a standard mean glandular dose (MGD) algorithm along with patient-specific volumetric breast density to give a better estimate of the dose absorbed by the specific breast.

For more information, visit www.volparasolutions.com.

Contact Us

Let us help you get started with Aspire today: Contact your Fujifilm representative, call +1-800-431-1850, or use our online contact form.

Meet Our Motivation

Fujifilm is constantly working to develop the most advanced digital mammography systems to assist in early breast cancer detection. Aspire Cristalle brings together Fujifilm's extensive research, expertise and experience.
Find out more about Aspire Cristalle